Novartis Investigative Site

Anyang-si, Gyeonggi-do 431-070

0 studies enrolling now · 4 studies all time

What they study most

Alport Syndrome, Cardiovascular Disease, Chronic Plaque Psoriasis, Diabetic Kidney Disease, Diabetic Nephropathy Type 2, Focal Segmental Glomerulosclerosis, IgA Nephropathy, Immunoglobulin A Nephropathy, Rheumatoid Arthritis, Type 2 Diabetes Mellitus

Studies at this site

• Atrasentan in Patients With Proteinuric Glomerular Diseases — Running, not enrolling
• Safety and Efficacy of Secukinumab Compared to Etanercept in Subjects With Moderate to Severe, Chronic Plaque-Type Psoriasis — Completed
• Efficacy, Safety and Tolerability of AIN457 in Patients With Rheumatoid Arthritis (RA) Taking Methotrexate (MTX) — Completed
• Aliskiren Trial in Type 2 Diabetes Using Cardiovascular and Renal Disease Endpoints (Core and Extension Phases) — Stopped early